Chemo is effective but notorious for causing heart failure.
While SGLT2 inhibitors are proven heart-protectors in diabetes/HF, do they work as a "shield" for chemo patients?
doi.org/10.7759/cureus.60086
#WeiPublications #CardioOncology #SGLT2i #Chemo #HeartFailure #FOAMed
While SGLT2 inhibitors are proven heart-protectors in diabetes/HF, do they work as a "shield" for chemo patients?
doi.org/10.7759/cureus.60086
#WeiPublications #CardioOncology #SGLT2i #Chemo #HeartFailure #FOAMed
Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Preventing Heart Failure in Patients Receiving Anthracycline-Based Cancer Therapy: A Systematic Review and Meta-Analysis
Anthracyclines are effective chemotherapeutic agents widely used to treat various cancers, but their use is limited by the risk of cardiotoxicity and heart failure. While strategies like dose reductio...
doi.org
January 3, 2026 at 10:02 PM
Chemo is effective but notorious for causing heart failure.
While SGLT2 inhibitors are proven heart-protectors in diabetes/HF, do they work as a "shield" for chemo patients?
doi.org/10.7759/cureus.60086
#WeiPublications #CardioOncology #SGLT2i #Chemo #HeartFailure #FOAMed
While SGLT2 inhibitors are proven heart-protectors in diabetes/HF, do they work as a "shield" for chemo patients?
doi.org/10.7759/cureus.60086
#WeiPublications #CardioOncology #SGLT2i #Chemo #HeartFailure #FOAMed
💓 New research from Achlaug et al. @technion.bsky.social reveals how cancer-driven cytokine signalling improves cardiac function and reduces fibrosis.
Tumour–heart crosstalk with major therapeutic implications
www.sciencedirect.com/science/arti...
#CardioOncology #Immunology #Fibrosis #Research
Tumour–heart crosstalk with major therapeutic implications
www.sciencedirect.com/science/arti...
#CardioOncology #Immunology #Fibrosis #Research
Cancer-driven cytokine immunomodulation ameliorates cardiac function and suppresses fibrosis
Heart failure remains a leading cause of morbidity and mortality worldwide, with limited progress in the development of novel therapies. It has been d…
www.sciencedirect.com
December 17, 2025 at 2:07 PM
💓 New research from Achlaug et al. @technion.bsky.social reveals how cancer-driven cytokine signalling improves cardiac function and reduces fibrosis.
Tumour–heart crosstalk with major therapeutic implications
www.sciencedirect.com/science/arti...
#CardioOncology #Immunology #Fibrosis #Research
Tumour–heart crosstalk with major therapeutic implications
www.sciencedirect.com/science/arti...
#CardioOncology #Immunology #Fibrosis #Research
📞 Calling all Imaging Experts - we need your help. Please fill out this survey to help us understand your successes and challenges in cardiac imaging for cancer patients.
Link: redcap.slms.ucl.ac.uk/surveys/?s=N...
#cardioonc #cardiacimaging #cardiooncology #cardiology #oncology #cancertreatment
Link: redcap.slms.ucl.ac.uk/surveys/?s=N...
#cardioonc #cardiacimaging #cardiooncology #cardiology #oncology #cancertreatment
December 16, 2025 at 5:30 PM
📞 Calling all Imaging Experts - we need your help. Please fill out this survey to help us understand your successes and challenges in cardiac imaging for cancer patients.
Link: redcap.slms.ucl.ac.uk/surveys/?s=N...
#cardioonc #cardiacimaging #cardiooncology #cardiology #oncology #cancertreatment
Link: redcap.slms.ucl.ac.uk/surveys/?s=N...
#cardioonc #cardiacimaging #cardiooncology #cardiology #oncology #cancertreatment
NEW #HeartToHeart Episode🫀
This week, we're joined by Francesca Ossani - a #cancer survivor and patient advocate - whose #cardiooncology journey helped her see the beauty in hope and sharing it with others.
🎧 Tune in: ic-os.org/podcast/hear...
#cardioonc #cancertreatment #TreatCancerProtectHearts
This week, we're joined by Francesca Ossani - a #cancer survivor and patient advocate - whose #cardiooncology journey helped her see the beauty in hope and sharing it with others.
🎧 Tune in: ic-os.org/podcast/hear...
#cardioonc #cancertreatment #TreatCancerProtectHearts
December 9, 2025 at 4:45 PM
NEW #HeartToHeart Episode🫀
This week, we're joined by Francesca Ossani - a #cancer survivor and patient advocate - whose #cardiooncology journey helped her see the beauty in hope and sharing it with others.
🎧 Tune in: ic-os.org/podcast/hear...
#cardioonc #cancertreatment #TreatCancerProtectHearts
This week, we're joined by Francesca Ossani - a #cancer survivor and patient advocate - whose #cardiooncology journey helped her see the beauty in hope and sharing it with others.
🎧 Tune in: ic-os.org/podcast/hear...
#cardioonc #cancertreatment #TreatCancerProtectHearts
Chemotherapy-induced vascular toxicity can lead to #CardiovascularDisease—even years after anti-cancer treatment.
Here, Andreas M. Beyer & team assessed microvasculature from tissue samples exposed to three anti-cancer agents: insight.jci.org/articles/vie...
#CardioOncology
Here, Andreas M. Beyer & team assessed microvasculature from tissue samples exposed to three anti-cancer agents: insight.jci.org/articles/vie...
#CardioOncology
November 26, 2025 at 5:15 PM
Chemotherapy-induced vascular toxicity can lead to #CardiovascularDisease—even years after anti-cancer treatment.
Here, Andreas M. Beyer & team assessed microvasculature from tissue samples exposed to three anti-cancer agents: insight.jci.org/articles/vie...
#CardioOncology
Here, Andreas M. Beyer & team assessed microvasculature from tissue samples exposed to three anti-cancer agents: insight.jci.org/articles/vie...
#CardioOncology
Want to influence cardio-oncology care worldwide?
EHJ–Cardio-Oncology invites applications for Editor-in-Chief — a chance to shape global research and clinical practice.
🗓️ Apply by 30 Nov 2025
🔗 Read more: oxford.ly/43hhezn
@escardio.bsky.social #CardioOncology
EHJ–Cardio-Oncology invites applications for Editor-in-Chief — a chance to shape global research and clinical practice.
🗓️ Apply by 30 Nov 2025
🔗 Read more: oxford.ly/43hhezn
@escardio.bsky.social #CardioOncology
November 9, 2025 at 2:00 PM
Want to influence cardio-oncology care worldwide?
EHJ–Cardio-Oncology invites applications for Editor-in-Chief — a chance to shape global research and clinical practice.
🗓️ Apply by 30 Nov 2025
🔗 Read more: oxford.ly/43hhezn
@escardio.bsky.social #CardioOncology
EHJ–Cardio-Oncology invites applications for Editor-in-Chief — a chance to shape global research and clinical practice.
🗓️ Apply by 30 Nov 2025
🔗 Read more: oxford.ly/43hhezn
@escardio.bsky.social #CardioOncology
🚨 LEADERSHIP ANNOUNCEMENT 🚨
As announced at #GCOS25, Susan Dent will be stepping down as President of IC-OS at the end of her term in December, with Michael Fradley taking over the role starting in 2026.
#ThankYouDrDent #cardioonc #cardiooncology #gcos2025
As announced at #GCOS25, Susan Dent will be stepping down as President of IC-OS at the end of her term in December, with Michael Fradley taking over the role starting in 2026.
#ThankYouDrDent #cardioonc #cardiooncology #gcos2025
November 6, 2025 at 4:38 PM
🚨 LEADERSHIP ANNOUNCEMENT 🚨
As announced at #GCOS25, Susan Dent will be stepping down as President of IC-OS at the end of her term in December, with Michael Fradley taking over the role starting in 2026.
#ThankYouDrDent #cardioonc #cardiooncology #gcos2025
As announced at #GCOS25, Susan Dent will be stepping down as President of IC-OS at the end of her term in December, with Michael Fradley taking over the role starting in 2026.
#ThankYouDrDent #cardioonc #cardiooncology #gcos2025
What is the difference between forward & reverse #CardioOncology? 🎧 Dr. Carol Ann Remme interviews Dr. Rudolf de Boer about #cardiotoxicity due to anti-cancer therapies vs. #cancer discovered more often in patients with #cardiovascular disease 🎙️https://ow.ly/hB1g50Xnn3C
November 5, 2025 at 8:12 PM
What is the difference between forward & reverse #CardioOncology? 🎧 Dr. Carol Ann Remme interviews Dr. Rudolf de Boer about #cardiotoxicity due to anti-cancer therapies vs. #cancer discovered more often in patients with #cardiovascular disease 🎙️https://ow.ly/hB1g50Xnn3C
QT Prolongation in Oncology: Practical Playbook, Risk–Benefit Balance, and the Road Ahead at GCOS 2025
@icosociety.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #CardioOncology
@icosociety.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #CardioOncology
QT Prolongation in Oncology: Practical Playbook, Risk–Benefit Balance, and the Road Ahead at GCOS 2025 - OncoDaily
QT Prolongation in Oncology: Practical Playbook, Risk–Benefit Balance, and the Road Ahead at GCOS 2025 / cancer, Cardio-Oncology, cardiology and oncology,
oncodaily.com
November 4, 2025 at 8:37 PM
QT Prolongation in Oncology: Practical Playbook, Risk–Benefit Balance, and the Road Ahead at GCOS 2025
@icosociety.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #CardioOncology
@icosociety.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #CardioOncology
GCOS 2025: Cardiac Imaging - What and When in Low-Resource Environment?
@icosociety.bsky.social
oncodaily.com/voices/gcos-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #Cardioonc #Cardiooncology #Cardiooncologia #Cardiooncologie
@icosociety.bsky.social
oncodaily.com/voices/gcos-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #Cardioonc #Cardiooncology #Cardiooncologia #Cardiooncologie
GCOS 2025: Cardiac Imaging - What and When in Low Resource Environment? - OncoDaily
GCOS 2025: Cardiac Imaging - What and When in Low Resource Environment? / cancer, GCOS, GCOS 2025, GCOS25, Ntobeko Ntusi, OncoDaily, Oncology
oncodaily.com
November 2, 2025 at 9:44 PM
GCOS 2025: Cardiac Imaging - What and When in Low-Resource Environment?
@icosociety.bsky.social
oncodaily.com/voices/gcos-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #Cardioonc #Cardiooncology #Cardiooncologia #Cardiooncologie
@icosociety.bsky.social
oncodaily.com/voices/gcos-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #Cardioonc #Cardiooncology #Cardiooncologia #Cardiooncologie
Day 2 of #GCOS2025 is a wrap - but we're not done yet!
Join us for one more day of learning and networking tomorrow starting at 8:20AM.
Plan your day: cososa.org.za/wp-content/u...
#cardioonc #cardiooncology #cardiooncologie #cardiooncologia #心臓腫瘍学 #kardioonkologie #GCOS25
Join us for one more day of learning and networking tomorrow starting at 8:20AM.
Plan your day: cososa.org.za/wp-content/u...
#cardioonc #cardiooncology #cardiooncologie #cardiooncologia #心臓腫瘍学 #kardioonkologie #GCOS25
October 31, 2025 at 9:00 PM
Day 2 of #GCOS2025 is a wrap - but we're not done yet!
Join us for one more day of learning and networking tomorrow starting at 8:20AM.
Plan your day: cososa.org.za/wp-content/u...
#cardioonc #cardiooncology #cardiooncologie #cardiooncologia #心臓腫瘍学 #kardioonkologie #GCOS25
Join us for one more day of learning and networking tomorrow starting at 8:20AM.
Plan your day: cososa.org.za/wp-content/u...
#cardioonc #cardiooncology #cardiooncologie #cardiooncologia #心臓腫瘍学 #kardioonkologie #GCOS25
🚨 MAJOR ANNOUNCEMENT FROM CAPE TOWN 🚨
Dr Susan Dent's term as President will come to an end in 2025. Thank you Dr Dent for all you do to advance #cardiooncology around the world.
Congrats to Mike Fradley, MD, who will take over as President on Jan 1, 2026.
#cardioonc
Dr Susan Dent's term as President will come to an end in 2025. Thank you Dr Dent for all you do to advance #cardiooncology around the world.
Congrats to Mike Fradley, MD, who will take over as President on Jan 1, 2026.
#cardioonc
October 31, 2025 at 5:28 PM
🚨 MAJOR ANNOUNCEMENT FROM CAPE TOWN 🚨
Dr Susan Dent's term as President will come to an end in 2025. Thank you Dr Dent for all you do to advance #cardiooncology around the world.
Congrats to Mike Fradley, MD, who will take over as President on Jan 1, 2026.
#cardioonc
Dr Susan Dent's term as President will come to an end in 2025. Thank you Dr Dent for all you do to advance #cardiooncology around the world.
Congrats to Mike Fradley, MD, who will take over as President on Jan 1, 2026.
#cardioonc
🌟A First at #GCOS2025🌟
The ICOS and European Society of Cardiology (@escardio) held a joint session on best practices and the future of #cardiooncology.
With our societies working together, we can continue to help drive better outcomes for the hearts of #cancer patients.
The ICOS and European Society of Cardiology (@escardio) held a joint session on best practices and the future of #cardiooncology.
With our societies working together, we can continue to help drive better outcomes for the hearts of #cancer patients.
October 31, 2025 at 2:33 PM
🌟A First at #GCOS2025🌟
The ICOS and European Society of Cardiology (@escardio) held a joint session on best practices and the future of #cardiooncology.
With our societies working together, we can continue to help drive better outcomes for the hearts of #cancer patients.
The ICOS and European Society of Cardiology (@escardio) held a joint session on best practices and the future of #cardiooncology.
With our societies working together, we can continue to help drive better outcomes for the hearts of #cancer patients.
Global Cardio-Oncology Summit (GC-OS) 2025: Access to Oncology Care. A Global Perspective
@icosociety.bsky.social
oncodaily.com/library/400920
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #Cardiooncology #Cardiooncologia
@icosociety.bsky.social
oncodaily.com/library/400920
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #Cardiooncology #Cardiooncologia
Access to Oncology Care. A Global Perspective
Access to oncology care remains unequal worldwide. GC-OS 2025 called for equity, prevention, and sustainable cancer care systems.
oncodaily.com
October 31, 2025 at 1:35 PM
Global Cardio-Oncology Summit (GC-OS) 2025: Access to Oncology Care. A Global Perspective
@icosociety.bsky.social
oncodaily.com/library/400920
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #Cardiooncology #Cardiooncologia
@icosociety.bsky.social
oncodaily.com/library/400920
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GCOS #GCOS25 #GCOS2025 #CardioOnc #Cardiooncology #Cardiooncologia
#GCOS25 starts NOW! Join us for our welcome session with Alexander Lyon (UK 🇬🇧), Trishun Singh (RSA 🇿🇦) and Susan Dent, MD FRCPC Dent (USA 🇺🇸 )
#cardioonc #cardiooncology
#cardioonc #cardiooncology
October 31, 2025 at 5:13 AM
#GCOS25 starts NOW! Join us for our welcome session with Alexander Lyon (UK 🇬🇧), Trishun Singh (RSA 🇿🇦) and Susan Dent, MD FRCPC Dent (USA 🇺🇸 )
#cardioonc #cardiooncology
#cardioonc #cardiooncology
What is the difference between forward and reverse #CardioOncology? Listen to the latest episode of The Physiological Reviews Podcast discussing #Cancer, #CardiovascularDisease, #HeartFailure, and #Cardiotoxicity 🎧
https://ow.ly/isSC50XhR4y
https://ow.ly/isSC50XhR4y
October 24, 2025 at 9:16 PM
What is the difference between forward and reverse #CardioOncology? Listen to the latest episode of The Physiological Reviews Podcast discussing #Cancer, #CardiovascularDisease, #HeartFailure, and #Cardiotoxicity 🎧
https://ow.ly/isSC50XhR4y
https://ow.ly/isSC50XhR4y
Look forward to sharing our work
@ahascience.bsky.social
#AHA25 From scRNA-seq to LLMs & AI-driven risk prediction, here’s how we’re decoding the intersection of cancer, immunity, & the heart. 💥👇 #CHIP #ICI #CardioOncology @yalecvrc.bsky.social @yalecancer.bsky.social
@Yale
@ahascience.bsky.social
#AHA25 From scRNA-seq to LLMs & AI-driven risk prediction, here’s how we’re decoding the intersection of cancer, immunity, & the heart. 💥👇 #CHIP #ICI #CardioOncology @yalecvrc.bsky.social @yalecancer.bsky.social
@Yale
October 19, 2025 at 4:57 PM
Look forward to sharing our work
@ahascience.bsky.social
#AHA25 From scRNA-seq to LLMs & AI-driven risk prediction, here’s how we’re decoding the intersection of cancer, immunity, & the heart. 💥👇 #CHIP #ICI #CardioOncology @yalecvrc.bsky.social @yalecancer.bsky.social
@Yale
@ahascience.bsky.social
#AHA25 From scRNA-seq to LLMs & AI-driven risk prediction, here’s how we’re decoding the intersection of cancer, immunity, & the heart. 💥👇 #CHIP #ICI #CardioOncology @yalecvrc.bsky.social @yalecancer.bsky.social
@Yale
Rare case of metastatic soft tissue #sarcoma invading the left atrium and pulmonary veins—an exceptional cardiac spread reviewed in detail. #CardioOncology #CaseReport #Oncology onlinelibrary.wiley.com/doi/10.1002/...
An Unusual Presentation of Metastatic Soft Tissue Sarcoma to the Left Atrium and Pulmonary Veins: A Case Report and Comprehensive Literature Review
A summary of the patient's history and treatment process.
onlinelibrary.wiley.com
October 19, 2025 at 5:33 AM
Rare case of metastatic soft tissue #sarcoma invading the left atrium and pulmonary veins—an exceptional cardiac spread reviewed in detail. #CardioOncology #CaseReport #Oncology onlinelibrary.wiley.com/doi/10.1002/...
記事の要約: 岡山大学の研究チームは、非小細胞肺がんの治療薬オシメルチニブを使用した患者が心不全で入院するリスクが2倍以上高まることを発表しました。この研究は、全国規模の医療データベースを用いて行われ、オシメルチニブで治療された患者1万1,391人と他の治療法を受けた10万8,144人を比較しました。研究結果は「JACC: CardioOncology」に掲載されており、特に高齢者や心不全、高血圧を持つ患者がさらに高リスクであることが示されています。オシメルチニブ治療中は、心機能の継続的な検査が重要とされています。
「医療 オシメルチニブ 心不全」に関する記事です: https://www.qlifepro.com/news/20251015/osimertinib.html
非小細胞肺がん、オシメルチニブ治療で心不全入院リスク2倍超－岡山大 | QLifePro
岡山大学は、非小細胞肺がんの治療薬であるオシメルチニブを使用した患者では、心不全で入院する可能性が高まることを明らかにしたと発表した。
www.qlifepro.com
October 15, 2025 at 11:21 PM
記事の要約: 岡山大学の研究チームは、非小細胞肺がんの治療薬オシメルチニブを使用した患者が心不全で入院するリスクが2倍以上高まることを発表しました。この研究は、全国規模の医療データベースを用いて行われ、オシメルチニブで治療された患者1万1,391人と他の治療法を受けた10万8,144人を比較しました。研究結果は「JACC: CardioOncology」に掲載されており、特に高齢者や心不全、高血圧を持つ患者がさらに高リスクであることが示されています。オシメルチニブ治療中は、心機能の継続的な検査が重要とされています。
Synapse: Your Connection to our MSK Authors
Meet: Richard M Steingart
Research Focus: Medicine; NE Emeritus
Cardiac safety of reduced cardiotoxicity surveillance during HER2-targeted therapy
synapse.mskcc.org/synapse/work...
#HER2Positive #BreastCancerResearch #Cardiotoxicity #CardioOncology
Meet: Richard M Steingart
Research Focus: Medicine; NE Emeritus
Cardiac safety of reduced cardiotoxicity surveillance during HER2-targeted therapy
synapse.mskcc.org/synapse/work...
#HER2Positive #BreastCancerResearch #Cardiotoxicity #CardioOncology
October 13, 2025 at 3:30 PM
Synapse: Your Connection to our MSK Authors
Meet: Richard M Steingart
Research Focus: Medicine; NE Emeritus
Cardiac safety of reduced cardiotoxicity surveillance during HER2-targeted therapy
synapse.mskcc.org/synapse/work...
#HER2Positive #BreastCancerResearch #Cardiotoxicity #CardioOncology
Meet: Richard M Steingart
Research Focus: Medicine; NE Emeritus
Cardiac safety of reduced cardiotoxicity surveillance during HER2-targeted therapy
synapse.mskcc.org/synapse/work...
#HER2Positive #BreastCancerResearch #Cardiotoxicity #CardioOncology
Cardioprotective effectiveness of SGLT2 inhibitors in older diabetic women with early-stage breast cancer following anthracycline- and/or trastuzumab-based treatment
@tamedoncol.bsky.social
@linglingtian.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#cardiooncology
@tamedoncol.bsky.social
@linglingtian.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#cardiooncology
October 3, 2025 at 9:44 PM
Cardioprotective effectiveness of SGLT2 inhibitors in older diabetic women with early-stage breast cancer following anthracycline- and/or trastuzumab-based treatment
@tamedoncol.bsky.social
@linglingtian.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#cardiooncology
@tamedoncol.bsky.social
@linglingtian.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#cardiooncology
TCRT is inviting submissions to the Special Collection: Harnessing AI in Cardio-Oncology.
Learn more: journals.sagepub.com/topic/collec...
@tcrtcancer.bsky.social
#CardioOncology #AIinMedicine #CancerCare
Learn more: journals.sagepub.com/topic/collec...
@tcrtcancer.bsky.social
#CardioOncology #AIinMedicine #CancerCare
September 24, 2025 at 1:44 PM
TCRT is inviting submissions to the Special Collection: Harnessing AI in Cardio-Oncology.
Learn more: journals.sagepub.com/topic/collec...
@tcrtcancer.bsky.social
#CardioOncology #AIinMedicine #CancerCare
Learn more: journals.sagepub.com/topic/collec...
@tcrtcancer.bsky.social
#CardioOncology #AIinMedicine #CancerCare
Clonal Hematopoiesis in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology www.jacc.org/doi/10.1016/...
Clonal Hematopoiesis in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review
www.jacc.org
September 19, 2025 at 1:27 AM
Clonal Hematopoiesis in Cancer and Cardiovascular Disease: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology www.jacc.org/doi/10.1016/...
🌍 Delighted to attend #MetaHEART in Riga 🇱🇻 with Bosnian cardiology researchers 🇧🇦 Drs Jelena Jovanic & Ivana Iveljić. Dr Iveljić will give her invited talk on her recently completed PhD in cardiooncology 🧬 a testament to the resilience & talent in our EU_COST research community. 🫀#proudmentor
September 18, 2025 at 4:35 AM
🌍 Delighted to attend #MetaHEART in Riga 🇱🇻 with Bosnian cardiology researchers 🇧🇦 Drs Jelena Jovanic & Ivana Iveljić. Dr Iveljić will give her invited talk on her recently completed PhD in cardiooncology 🧬 a testament to the resilience & talent in our EU_COST research community. 🫀#proudmentor
We have a busy Fall / Winter conference season ahead of us.
Join one of these important events virtually or in a location near you.
See all events: ic-os.org/events
#cardioonc #cardiooncology #healthcareconference
Join one of these important events virtually or in a location near you.
See all events: ic-os.org/events
#cardioonc #cardiooncology #healthcareconference
September 15, 2025 at 5:09 PM
We have a busy Fall / Winter conference season ahead of us.
Join one of these important events virtually or in a location near you.
See all events: ic-os.org/events
#cardioonc #cardiooncology #healthcareconference
Join one of these important events virtually or in a location near you.
See all events: ic-os.org/events
#cardioonc #cardiooncology #healthcareconference